1. Search Result
Search Result
Results for "

2568358-31-4

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-145633
    Sozinibercept

    OPT 302; VGX-300

    VEGFR Cardiovascular Disease
    Sozinibercept (OPT 302; VGX-300) is a soluble form of VEGFR-3, potently inhibits the activity of VEGF-C/D, which are the proangiogenic factors, inhibiting angiogenesis and vascular leakage. Sozinibercept also inhibits diabetic retinal edema in rats.